Similar Search Results

Health Insurance Expansions and Provider Behavior : Evidence from Substance Use Disorder Providers

Maclean, Johanna Catherine - 2017

We examine how substance use disorder (SUD) treatment providers respond to private health insurance expansions induced by state equal coverage ('parity') laws for SUD treatment. We use data on the near universe of specialty SUD treatment providers in the United States between 1997 and 2010 in an...

Persistent link: https://www.econbiz.de/10012965014

Health insurance expansions and provider behavior : evidence from substance use disorder providers

Maclean, Johanna Catherine; Popovici, Ioana; Stern, … - 2017

Persistent link: https://www.econbiz.de/10011596165

Does Consolidation in Insurer Markets affect Insurance Enrollment and Drug Expenditures? : Evidence from Medicare Part D

Chatterji, Pinka; Ho, Chun-Yu; Jin, Tao; Wang, Yichuan - National Bureau of Economic Research - 2024

Since the inception of Medicare Part D in 2006, mergers and acquisitions (M&A) and regulatory changes have led to increased concentration and reduced plan variety in the standalone prescription drug plan (PDP) portion of the market. We examine how this industry consolidation affects Medicare...

Persistent link: https://www.econbiz.de/10014512121

From Bushfires to COVID-19 : Forewarning Indicators of Coronavirus Pandemic in Australia

Bosupeng, Mpho - 2021

The purpose of this study is to determine the leading indicators of the COVID-19 pandemic in Australia using daily data … predict a financial crisis to examine 30 COVID-19 indicators in Australia. The results show that the best indicator of the … current pandemic in Australia is the number of new tests. Other significant variables that are important for monitoring the …

Persistent link: https://www.econbiz.de/10013234580

Provider responses to the expansion of public subsidies in healthcare : the case of oral chemotherapy treatment in Australia

Naghsh Nejad, Maryam; Yu, Serena; Haywood, Philip - 2023

New South Wales, Australia. Our estimates indicate that the subsidies expanded access to oral chemotherapy for newly …

Persistent link: https://www.econbiz.de/10014249952

Mutual health insurance and its contribution to improving child health in Rwanda

Binagwaho, Agnes; Hartwig, Renate; Ingeri, Denyse; … - 2012

Rwanda is among the few countries in Sub-Saharan Africa and the developing approaching universal health insurance coverage. To date, over 90 per cent of the population are enrolled in the Mutuelles de Santé - a system that started off from a number of stand-alone community based health...

Persistent link: https://www.econbiz.de/10010310738

Re-evaluating an evaluation study: The case of the German health care reform of 1997

Winkelmann, Rainer - 2003

This paper reports on a re-evaluation of the German health care reform of 1997. A previous evaluation found a limited effect of a 4.4 percent reduction of the number of doctor visits in a sample of pharmacy customers. The re-evaluation based on a representative household survey, the German...

Persistent link: https://www.econbiz.de/10010315525

Does pharmaceutical price regulation affect the adoption of generic competition? Evidence from the OECD, 1999-2008

Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011

Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...

Persistent link: https://www.econbiz.de/10010274736

Germany's Struggle with Prices for Patent-protected Drugs

Kifmann, Mathias; Neelsen, Sven - In: CESifo DICE Report 08 (2010) 3, pp. 43-52

Persistent link: https://www.econbiz.de/10011696717

Assessing the Effectiveness of Health Care Cost Containment Measures

Ziebarth, Nicolas R. - 2011

Using SOEP panel data and difference-in-differences methods, this study is the first to empirically evaluate the effectiveness of four different health care cost containment measures within an integrated framework. The four measures investigated were introduced in Germany in 1997 to reduce moral...

Persistent link: https://www.econbiz.de/10011600994